The store will not work correctly when cookies are disabled.
methyl 8-cyclopropyl-9-oxo-8,9-dihydrothiazolo[5,4-f]quinazoline-2-carbimidate
ID: ALA4279616
PubChem CID: 145981446
Max Phase: Preclinical
Molecular Formula: C14H12N4O2S
Molecular Weight: 300.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=N)c1nc2ccc3ncn(C4CC4)c(=O)c3c2s1
Standard InChI: InChI=1S/C14H12N4O2S/c1-20-12(15)13-17-9-5-4-8-10(11(9)21-13)14(19)18(6-16-8)7-2-3-7/h4-7,15H,2-3H2,1H3
Standard InChI Key: YJGOBAYVKWEVDD-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
5.7549 -19.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4630 -20.1436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1698 -18.9115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1686 -19.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8748 -20.1411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5867 -19.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5879 -18.9135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8772 -18.4999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7561 -18.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4610 -18.5015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2855 -17.7032 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.4720 -17.6234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1449 -18.3724 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2966 -18.5066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8772 -17.6827 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0585 -16.9186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4621 -16.2080 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2413 -16.9243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8278 -16.2195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1115 -18.5085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7046 -17.7998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 1 2 0
1 2 1 0
2 4 2 0
3 10 2 0
3 4 1 0
3 8 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 9 1 0
7 14 1 0
8 15 2 0
12 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
20 14 1 0
21 20 1 0
14 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.34 | Molecular Weight (Monoisotopic): 300.0681 | AlogP: 2.31 | #Rotatable Bonds: 2 |
Polar Surface Area: 80.86 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.99 | CX LogP: 1.71 | CX LogD: 1.71 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.58 | Np Likeness Score: -0.73 |
References
1. Jarhad DB, Mashelkar KK, Kim HR, Noh M, Jeong LS.. (2018) Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics., 61 (22): [PMID:29985601] [10.1021/acs.jmedchem.8b00185] |